TWI:NYSETitan International, Inc. (DE) Analysis
Data as of 2026-05-06 - not real-time
$8.11
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Titan International’s stock is trading just above its 20‑day SMA and marginally above the 50‑day SMA, yet remains well below the 200‑day SMA, indicating short‑term momentum but long‑term weakness. The RSI sits near the midpoint and the MACD has turned bearish, while volatility is elevated (over 50% 30‑day) and beta is close to 1.8, underscoring a high‑risk price profile.
Fundamentally, the company shows modest revenue growth but continues to generate negative profit margins, a negative ROE and a debt‑to‑equity ratio above 140%, with cash balances insufficient to cover total debt. Despite these challenges, forward EPS is projected positive, the price‑to‑book is near parity, and analysts have issued a strong‑buy consensus with a median target near $12, implying upside of roughly 40% and an “Extreme Greed” market sentiment. Recent Q1 commentary described a “solid start” and participation in the Oppenheimer Industrial Growth Conference may provide additional visibility, though a recent large shareholder sale adds a short‑term supply pressure.
Fundamentally, the company shows modest revenue growth but continues to generate negative profit margins, a negative ROE and a debt‑to‑equity ratio above 140%, with cash balances insufficient to cover total debt. Despite these challenges, forward EPS is projected positive, the price‑to‑book is near parity, and analysts have issued a strong‑buy consensus with a median target near $12, implying upside of roughly 40% and an “Extreme Greed” market sentiment. Recent Q1 commentary described a “solid start” and participation in the Oppenheimer Industrial Growth Conference may provide additional visibility, though a recent large shareholder sale adds a short‑term supply pressure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD histogram
- High short‑term volatility
- Support level near $7.21
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst consensus strong‑buy with 44% upside
- Forward EPS turning positive
- Potential demand recovery in agricultural and construction segments
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued price‑to‑sales and price‑to‑book ratios
- Strategic global footprint across farm and heavy‑construction markets
- Long‑term upside potential despite current leverage
Key Metrics & Analysis
Financial Health
Revenue Growth2.90%
Profit Margin-4.72%
P/E Ratio23.7
ROE-16.42%
ROA0.80%
Debt/Equity147.25
P/B Ratio1.0
Op. Cash Flow$22.1M
Free Cash Flow$-13507750
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI52.4
Support$7.21
Resistance$8.71
MA 20$8.08
MA 50$8.00
MA 200$8.40
MACDBearish
VolumeStable
Fear & Greed Index90.38
Valuation
Target Price$11.75
Upside/Downside44.88%
GradeFair
TypeBlend
Risk Assessment
Beta1.79
Volatility57.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.